The U.S. Food and Drug Administration (FDA) granted fast track designation to the ATR inhibitor alnodesertib plus low-dose ...

After a stage 3b rectal cancer diagnosis, one patient endured radiation, chemotherapy, surgery, and complications, relying on resilience, advocacy and support.

At Hackensack Meridian Health University Medical Center’s John Theurer Cancer Center (JTCC), the Adult Stem Cell transplant ...

Davis, who is 30 years old, is the mother of a 16-month-old son and works as a pediatric emergency room nurse at Hackensack ...

I am living proof that a breast cancer diagnosis doesn’t have to be the end of your story. In fact, it can be the beginning of a richer, more meaningful life. Each day, I choose to celebrate survival ...

Panelists discuss how MICVO treatment caused manageable adverse effects, including occasional neuropathy in the patient's left leg that he addresses with compression socks, while he chose to remain in ...

Panelists discuss how the patient became a candidate for the MICVO trial after pembrolizumab showed limited progress, with the targeted therapy causing significantly less fatigue while allowing him to ...

Panelists discuss how preliminary MICVO data showed promising results with about half of patients with head and neck cancer achieving 30% or more tumor regression, including the patient's complete ...

Panelists discuss how MICVO, an antibody-drug conjugate (ADC), works by targeting fibronectin in the tumor microenvironment rather than cancer cells directly, delivering a chemotherapy payload in a ...

Panelists discuss how head and neck cancer treatment has evolved to include combined therapeutic approaches using surgery, radiation, chemotherapy with cisplatin, and newer immunotherapies, such as ...

Panelists discuss how newly diagnosed head and neck cancer patients should embrace their medical teams, connect with other patients in treatment centers, and remain hopeful about ongoing clinical ...

Panelists discuss how the patient experienced radiation and chemotherapy treatments with minimal adverse effects, maintaining an active lifestyle throughout, before transitioning to pembrolizumab ...